loadpatents
name:-0.021976947784424
name:-0.015163898468018
name:-0.00064206123352051
Mantei; Robert A. Patent Filings

Mantei; Robert A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mantei; Robert A..The latest application filed is for "bromodomain inhibitors".

Company Profile
3.30.41
  • Mantei; Robert A. - Franklin WI
  • Mantei; Robert A - Franklin WI
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Bromodomain Inhibitors
App 20210236508 - Wang; Le ;   et al.
2021-08-05
Tetracyclic Bromodomain Inhibitors
App 20210070756 - Fidanze; Steven D. ;   et al.
2021-03-11
Tetracyclic Bromodomain Inhibitors
App 20200291027 - Fidanze; Steven D. ;   et al.
2020-09-17
Tetracyclic Bromodomain Inhibitors
App 20190389861 - Fidanze; Steven D. ;   et al.
2019-12-26
Bromodomain Inhibitors
App 20180296566 - Wang; Le ;   et al.
2018-10-18
Tetracyclic Bromodomain Inhibitors
App 20180298003 - Fidanze; Steven D. ;   et al.
2018-10-18
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20180251426 - Bruncko; Milan ;   et al.
2018-09-06
Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors
Grant 10,035,800 - Fidanze , et al. July 31, 2
2018-07-31
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20160304451 - Elmore; Steven W. ;   et al.
2016-10-20
Dihydro-pyrrolopyridinone Inhibitors
App 20160237084 - Wang; Le ;   et al.
2016-08-18
Bromodomain Inhibitors
App 20160143916 - Wang; Le ;   et al.
2016-05-26
Dihydro-pyrrolopyridinone inhibitors
Grant 9,321,764 - Wang , et al. April 26, 2
2016-04-26
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,303,025 - Bruncko , et al. April 5, 2
2016-04-05
Bromodomain inhibitors
Grant 9,296,741 - Wang , et al. March 29, 2
2016-03-29
Tetracyclic Bromodomain Inhibitors
App 20160039821 - Fidanze; Steven D. ;   et al.
2016-02-11
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,174,982 - Bruncko , et al. November 3, 2
2015-11-03
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 9,125,913 - Bruncko , et al. September 8, 2
2015-09-08
BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 9,073,855 - Doherty , et al. July 7, 2
2015-07-07
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 9,072,748 - Bruncko , et al. July 7, 2
2015-07-07
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20150183775 - BRUNCKO; Milan ;   et al.
2015-07-02
Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition
Grant 9,051,315 - Ba-maung , et al. June 9, 2
2015-06-09
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 9,045,420 - Doherty , et al. June 2, 2
2015-06-02
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,029,404 - Doherty , et al. May 12, 2
2015-05-12
Dihydro-pyrrolopyridinone Inhibitors
App 20140275026 - Wang; Le ;   et al.
2014-09-18
Bromodomain Inhibitors
App 20140162971 - WANG; Le ;   et al.
2014-06-12
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20140113910 - Bruncko; Milan ;   et al.
2014-04-24
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20140107119 - Bruncko; Milan ;   et al.
2014-04-17
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20140094471 - Bruncko; Milan ;   et al.
2014-04-03
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20140088106 - Bruncko; Milan ;   et al.
2014-03-27
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20140066621 - Bruncko; Milan ;   et al.
2014-03-06
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20140057890 - Bruncko; Milan ;   et al.
2014-02-27
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20140057889 - Bruncko; Milan ;   et al.
2014-02-27
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 8,586,754 - Bruncko , et al. November 19, 2
2013-11-19
Bcl-2 Selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20130296295 - BRUNCKO; Milan ;   et al.
2013-11-07
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 8,563,735 - Bruncko , et al. October 22, 2
2013-10-22
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,557,983 - Doherty , et al. October 15, 2
2013-10-15
Pyrimidine inhibitors of kinase activity
Grant 8,536,180 - Clark , et al. September 17, 2
2013-09-17
Pyrimidine inhibitors of kinase activity
Grant 8,486,933 - Wang , et al. July 16, 2
2013-07-16
Pyrimidine inhibitors of kinase activity
Grant 8,354,422 - Clark , et al. January 15, 2
2013-01-15
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20120190688 - Bruncko; Milan ;   et al.
2012-07-26
Protein kinase inhibitors
Grant 8,067,409 - Ba-Maung , et al. November 29, 2
2011-11-29
Imidazopyridines As A Novel Scaffold For Multi-targeted Kinase Inhibition
App 20110124632 - Ba-maung; Nwe Y. ;   et al.
2011-05-26
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20100305122 - Bruncko; Milan ;   et al.
2010-12-02
Pyrimidine Inhibitors Of Kinase Activity
App 20100305112 - Wang; Gary T. ;   et al.
2010-12-02
Pyrimidine Inhibitors of Kinase Activity
App 20100305126 - Clark; Richard F. ;   et al.
2010-12-02
Pyrimidine Inhibitors Of Kinase Activity
App 20100305118 - Clark; Richard F. ;   et al.
2010-12-02
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20100298323 - Bruncko; Milan ;   et al.
2010-11-25
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20100298321 - Bruncko; Milan ;   et al.
2010-11-25
Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors
Grant 7,772,231 - Sheppard , et al. August 10, 2
2010-08-10
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20100160322 - Bruncko; Milan ;   et al.
2010-06-24
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20100152183 - Bruncko; Milan ;   et al.
2010-06-17
Protein Kinase Inhibitors
App 20090253723 - Ba-Maung; Nwe Y. ;   et al.
2009-10-08
Sulfonamides having antiangiogenic and anticancer activity
Grant 7,491,718 - Comess , et al. February 17, 2
2009-02-17
Farnesyltransferase inhibitors
Grant 7,323,570 - Claiborne , et al. January 29, 2
2008-01-29
Protein Kinase Inhibitors
App 20070203143 - Sheppard; George S. ;   et al.
2007-08-30
Farnesyltransferase inhibitors
Grant 7,211,595 - Claiborne , et al. May 1, 2
2007-05-01
Farnesyltransferase Inhibitors
App 20060264476 - Claiborne; Akiyo K. ;   et al.
2006-11-23
Urea kinase inhibitors
Grant 7,056,925 - Li , et al. June 6, 2
2006-06-06
Urea kinase inhibitors
App 20040259885 - Li, Gaoquan ;   et al.
2004-12-23
Sulfonamides having antiangiogenic and anticancer activity
App 20040167128 - Comess, Kenneth M. ;   et al.
2004-08-26
Sulfonamides having antiangiogenic and anticancer activity
App 20040157836 - Comess, Kenneth M. ;   et al.
2004-08-12
Urea kinase inhibitors
App 20040034038 - Li, Goaquan ;   et al.
2004-02-19
Farnesyltransferase inhibitors
App 20030087940 - Claiborne, Akiyo K. ;   et al.
2003-05-08
Farnesyltransferase inhibitors
App 20020115640 - Claiborne, Akiyo K. ;   et al.
2002-08-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed